Multicenter study demonstrates accurate differentiation between glioblastoma and lymphoma using spatial radiomics, highlighting distinct anatomical and biological tumor niches.
Glioblastoma (GBM) and primary central nervous system lymphoma (PCNSL) often exhibit overlapping appearances on routine MRI, complicating pre-treatment diagnosis. In 1,109 patients from five centers, we constructed standard-space tumor probabilistic maps and derived atlas-anchored spatial features to augment conventional radiomics. The spatial radiomics classifier outperformed radiomics alone (external test area under the ROC curve [AUC], 0.98) with acceptable calibration and decision curve benefit, and SHapley Additive exPlanations (SHAP)-enabled anatomy-grounded interpretation. Aligning tumor localization with the Allen Human Brain Atlas and a normative functional connectome linked GBM-enriched territories to developmental-oncogenic programs and network hubness, whereas PCNSL-enriched territories showed immune-inflammatory/proliferative programs, and associations with network hubness did not survive spatial-autocorrelation correction. These results provide shareable reference maps and an interpretable, multicenter-generalizing tool for GBM-PCNSL differentiation, while offering biological context for diagnosis-specific location susceptibility.
No takes yet. Share an insight, caveat, or question.
Wáng et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: